ABSTRACT
No disponible
No disponible
Subject(s)
Humans , Female , Infant , Discitis , Electromyography/trends , Electromyography , Radiculopathy/complications , Radiculopathy , Cloxacillin/therapeutic use , Cefuroxime/therapeutic use , Kyphosis/complications , Kyphosis/diagnosis , Early Diagnosis , Discitis/complications , Discitis/diagnosis , Emergencies , Motor Activity/physiology , Diagnosis, DifferentialSubject(s)
Discitis/complications , Intestinal Diseases/etiology , Discitis/diagnosis , Female , Humans , Infant , Time FactorsSubject(s)
Humans , Male , Female , Infant , Child, Preschool , Calcitonin/analysis , Mucocutaneous Lymph Node Syndrome/diagnosis , Biomarkers/analysisSubject(s)
Calcitonin/blood , Coronary Aneurysm/blood , Coronary Aneurysm/etiology , Mucocutaneous Lymph Node Syndrome/blood , Mucocutaneous Lymph Node Syndrome/complications , Protein Precursors/blood , Calcitonin Gene-Related Peptide , Child, Preschool , Female , Humans , Infant , Male , Predictive Value of TestsSubject(s)
Humans , Male , Female , Child , Mucocutaneous Lymph Node Syndrome/drug therapy , Ibuprofen , Drug Interactions , Aspirin/pharmacokineticsABSTRACT
Hafnia alvei es una bacilo gran negativo, reconocido como un agente etiológico de patologías tales como bacteriemias, neumonías o infecciones urinarias. Ocasionalmente se le ha relacionado con cuadros digestivos, no quedando claro su papel enteropatógeno. Queremos documentar dos casos de aislamiento de Hafnia alvei y discutir su implicación clínica (AU)
Hafnia alvei is a gram negative bacilli, that it has been recognized as an etiologic agent in bacteriemias, pneumonias or urinary tract infections. It can cause diarrheal disease, but the possible role of Hafnia in bacterial gastroenteritis is presently unknown. We describe two child with Hafnia alvei and discuss its clinical significance (AU)
Subject(s)
Humans , Female , Child , Hafnia alvei/isolation & purification , Gastroenteritis/diagnosis , Hafnia alvei/pathogenicity , Gastroenteritis/etiology , Gastroenteritis/microbiology , Gram-Negative Bacterial Infections/microbiology , Feces/microbiology , Abdominal PainABSTRACT
No disponible
Subject(s)
Male , Child , Humans , Mucocutaneous Lymph Node Syndrome/complications , Mucocutaneous Lymph Node Syndrome/diagnosis , Mucocutaneous Lymph Node Syndrome/therapy , Exanthema/complications , Exanthema/diagnosis , Radiography, Thoracic/methods , Aspirin/therapeutic use , Conjunctivitis/complications , Polymerase Chain Reaction/methods , Leukocytes/metabolism , Leukocytes/pathologyABSTRACT
No disponible
Subject(s)
Male , Child, Preschool , Humans , Neisseriaceae Infections/drug therapy , Meningitis/drug therapy , Kingella kingae/pathogenicity , Kingella kingae , Neisseriaceae Infections/diagnosis , Meningitis/diagnosis , Cefotaxime/therapeutic use , Vancomycin/therapeutic use , Dexamethasone/therapeutic useABSTRACT
La ceftriaxona se elimina en un 40 por ciento por vía biliar y, debido a su afinidad por el calcio, puede precipitar y originar una litiasis biliar. Se ha comprobado que el 12-45 por ciento de los pacientes que reciben ceftriaxona suelen desarrollar imágenes ecográficas de litiasis biliar, tan precozmente como al segundo día de tratamiento. La colelitiasis suele ser asintomática y desaparece antes de los 2 meses de finalizar la ceftriaxona. Se han descrito algunos casos sintomáticos y, en ocasiones, han precisado tratamiento quirúrgico. Se presentan cuatro casos de niños, atendidos durante 1999, que desarrollaron colelitiasis asintomática entre el segundo y cuarto día de tratamiento con ceftriaxona. La litiasis biliar se resolvió de forma espontánea entre uno y cuatro meses después de finalizar el tratamiento (AU)
Subject(s)
Child, Preschool , Child , Male , Humans , Ceftriaxone , Cephalosporins , CholelithiasisABSTRACT
OBJECTIVE: To describe a case of scrotal cavernous hemangioma. METHODS: A 4-year old boy with a painful left scrotal mass is described. The epidemiology, natural history, diagnosis, differential diagnosis, treatment and prognosis of this tumor are reviewed. RESULTS: Analysis of the surgical specimen disclosed a scrotal cavernous hemangioma. CONCLUSIONS: A scrotal mass diagnosed at an uncommon age or atypical site warrants considering hemangioma as a possible etiology.
Subject(s)
Genital Neoplasms, Male , Hemangioma, Cavernous , Scrotum , Child, Preschool , Genital Neoplasms, Male/pathology , Genital Neoplasms, Male/surgery , Hemangioma, Cavernous/pathology , Hemangioma, Cavernous/surgery , Humans , MaleABSTRACT
A four-month-old boy affected by glycogen storage disease type I is presented. The child suffered from hepatomegaly, lactic acidosis, fasting hypoglycemia and failure to thrive. He had repeated infectious and cyclic neutropenia. Immunoglobulin and chemotactic neutrophil motility was impaired. Liver biopsy showed increased amounts of glycogen in hepatic cells as assessed by morphological and biochemical grounds. The activity of glucose-6-phosphatase as well as other glycogenolytic enzymes was normal in the frozen liver. The aforementioned characteristics suggested the diagnosis of glycogen storage disease type Ib. The child was first treated by enteral continuous feeding and later on by frequent meals during the daytime and enteral continuous feeding during the night time, improving the hypoglycemia as well as the other biochemical and metabolic abnormalities.
